XML 65 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues        
Rental income $ 46,079 $ 31,693 $ 127,941 $ 99,206
Interest on loans and financing lease 1,101 1,131 3,263 3,272
Interest and other income 191 49 1,232 128
Total revenues 47,371 32,873 132,436 102,606
Expenses        
Interest expense incurred 12,376 8,577 36,489 29,599
Amortization of deferred financing costs 988 810 2,944 2,516
Depreciation and amortization 11,522 8,302 31,470 24,399
General and administrative 5,297 3,867 16,960 21,150
Transaction costs 1,220 1,210 3,813 1,906
Loss on impairment 1,479   2,341  
Reserve for uncollectible loans and other receivables 9 27 3,509 57
Loss (gain) on sale of assets, net 2,445 13 2,458 (26)
Loss on extinguishment of debt     501 10,974
Total expenses 35,336 22,806 100,485 90,575
Net income 12,035 10,067 31,951 12,031
Net income allocable to noncontrolling interests - operating partnership (2,344) (2,446) (6,662) (3,236)
Net income allocable to common stockholders 9,691 7,621 25,289 8,795
Basic:        
Net income allocable to common stockholders $ 0.21 $ 0.20 $ 0.58 $ 0.27
Diluted:        
Net income allocable to common stockholders $ 0.20 $ 0.20 $ 0.56 $ 0.26
Weighted average common shares/units outstanding:        
Basic 47,213,612 37,271,714 43,576,705 32,408,843
Diluted 60,967,867 50,838,529 57,127,784 42,101,077
Dividends declared per common share $ 0.360 $ 0.360 $ 1.080 $ 0.744
Aviv Healthcare Properties Limited Partnership
       
Revenues        
Rental income 46,079 31,693 127,941 99,206
Interest on loans and financing lease 1,101 1,131 3,263 3,272
Interest and other income 191 49 1,232 128
Total revenues 47,371 32,873 132,436 102,606
Expenses        
Interest expense incurred 12,376 8,577 36,489 29,599
Amortization of deferred financing costs 988 810 2,944 2,516
Depreciation and amortization 11,522 8,302 31,470 24,399
General and administrative 5,297 3,867 16,960 21,150
Transaction costs 1,220 1,210 3,813 1,906
Loss on impairment 1,479   2,341  
Reserve for uncollectible loans and other receivables 9 27 3,509 57
Loss (gain) on sale of assets, net 2,445 13 2,458 (26)
Loss on extinguishment of debt     501 10,974
Total expenses 35,336 22,806 100,485 90,575
Net income 12,035 10,067 31,951 12,031
Net income allocable to noncontrolling interests - operating partnership       (1,008)
Net income allocable to common stockholders $ 12,035 $ 10,067 $ 31,951 $ 11,023
Basic:        
Net income allocable to common stockholders $ 0.21 $ 0.20 $ 0.58 $ 0.27
Diluted:        
Net income allocable to common stockholders $ 0.20 $ 0.20 $ 0.56 $ 0.26
Weighted average common shares/units outstanding:        
Basic 58,633,389 49,210,134 55,055,248 40,630,173
Diluted 60,967,867 50,838,529 57,127,784 42,101,077
Dividends declared per common share $ 0.360 $ 0.360 $ 1.080 $ 0.744